Andreia Almeida 1, Marco Araújo 2, Ramon Novoa-Carballal 3, Fernanda Andrade 4, Hugo Gonçalves 5, Rui L Reis 3, Marlene Lúcio 6, Simó Schwartz Jr 7, Bruno Sarmento 8 PMID: 32409071 DOI: 10.1016/j.msec.2020.110920 Abstract Chitosan was grafted...
Read moreSimvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease
Diana Hide 1, Mar Gil 2, Fernanda Andrade 3, Diana Rafael 4, Imma Raurell 5, Miren Bravo 6, Aurora Barberá 7, Jordi Gracia-Sancho 8, Víctor Vargas 9, Salvador Augustin 10, Joan Genescà 11, Simo Schwartz Jr 12, Maria Martell 13 PMID: 32681987 DOI...
Read moreTres investigadores del VHIR reciben una beca de la Asociación Española Contra el Cáncer
La Asociación Española Contra el Cáncer (AECC) ha presentado hoy, con motivo del Día Mundial de la Investigación en Cáncer, la resolución de las becas para ayudar a la investigación contra el cáncer. Entre los candidatos escogidos se encuentran...
Read moreCerium oxide nanoparticles may improve hepatocellular carcinoma prognosis
Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C viruses, alcoholism, metabolic diseases of the liver and exposure to certain toxins...
Read moreICND2020: International Conference on Nanomedicine and Drug Delivery Systems
More information
Read moreManaging Zileuton by means of polymeric micelles significantly reduces the tumor stem cells of breast cancer within the tumor and in the bloodstream
The CIBBIM-Nanomedicine. Drug Delivery and Targeting Group of the Vall d’Hebron Research Institute (VHIR) has conducted a study to measure the effectiveness of Zileuton ™, a drug that is indicated for the treatment of asthma, administered...
Read moreNew antitumoral drug release strategy created for breast cancer treatment
Researchers from the CIBBIM-Nanomedicine Drug Delivery and Trageting of the Vall d’Hebron Research Institute (VHIR) and CIBER-BBN with Dr. Ibane Abasolo at the head, have studied the viability of the bacterial inclusion bodies as a method...
Read moreClinical Nanomedicine and Advanced Therapies Research Centre. The Pharmacokinetics of Nanoparticles
The Nanoparticle Design and Pharmacodynamics group focuses on the synthesis, characterisation and applications of inorganic nanoparticle engineering in the field of medicine. The group’s aim is to design nanoparticles that can interact with...
Read moreThe Dra. Anna M. Meseguer awarded by the College of Biologists of Catalonia
Yesterday evening, on the occasion of the Biologist’s Day, Dr. Anna Meseguer picked up the Research and Investigation Prize awarded by the College of Biologists of Catalonia in recognition of her contribution to scientific advances and the...
Read moreSafe-N-Medtech kicks off in Bilbao
The Safe-N-Medtech initiative just kicked off last week in Bilbao, in a meeting hosted by Osteba, the HTA Unit of the Health Ministry of the Basque Country (Spain) in collaboration with BIOPRAXIS-BIOKERALTY. The project is coordinated by TECNAN...
Read moreHow former Elsevier editors started a community-led publisher and launched their first OA journal
After serving as editor-in-chief of Nanomedicine: Nanotechnology, Biology and Medicine for over seven years, Lajos Balogh knew that he had the skills and expertise needed to run an academic journal. An ardent open access (OA) advocate, Balogh...
Read moreHighlighted presence of VHIR researchers at the 11th Jornada de Recerca de l’ICS
On May 23, 2019, the Centre Tarraconense El Seminari will host the 11th Research Day organized by the Catalan Health Institute involving several researchers from the Vall d’Hebron Research Institute (VHIR). This year, is dedicated to...
Read more
